Testing effectiveness (Phase 2)Active Not RecruitingNCT06561425
What this trial is testing
A Study Evaluating the Safety and Efficacy of GLPG5101 (19CP02) in Participants With Non-Hodgkin Lymphoma
Who this might be right for
Relapsed/Refractory B-cell Non-Hodgkin LymphomaLymphomas Non-Hodgkin&Amp;Amp;#39;s B-Cell
Galapagos NV 274